Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Retatrutide (LY3437943) is an investigational triple-hormone receptor agonist developed by Eli Lilly that targets the GIP, GLP-1, and glucagon receptors simultaneously
Developing a Hydration Strategy Instead of relying solely on thirst, you need to develop a hydration strategy
If you need targets, a clinician or dietitian can tailor them to you
Amazing experience and will be ordering again
Potential Program Benefits May provide convenient access to an online medical weight-management evaluation
This comprehensive trial program will help us understand which patient populations benefit most
US$ 28.27
US$ 24.36
US$ 25.67
US$ 29.30
US$ 23.78
US$ 29.23
US$ 20.89
US$ 22.57
US$ 22.07
